Literature DB >> 16892036

Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness.

Jolanta M Topczewska1, Lynne-Marie Postovit, Naira V Margaryan, Anthony Sam, Angela R Hess, William W Wheaton, Brian J Nickoloff, Jacek Topczewski, Mary J C Hendrix.   

Abstract

Bidirectional cellular communication is integral to both cancer progression and embryological development. In addition, aggressive tumor cells are phenotypically plastic, sharing many properties with embryonic cells. Owing to the similarities between these two types of cells, the developing zebrafish can be used as a biosensor for tumor-derived signals. Using this system, we show that aggressive melanoma cells secrete Nodal (a potent embryonic morphogen) and consequently can induce ectopic formation of the embryonic axis. We further show that Nodal is present in human metastatic tumors, but not in normal skin, and thus may be involved in melanoma pathogenesis. Inhibition of Nodal signaling reduces melanoma cell invasiveness, colony formation and tumorigenicity. Nodal inhibition also promotes the reversion of melanoma cells toward a melanocytic phenotype. These data suggest that Nodal signaling has a key role in melanoma cell plasticity and tumorigenicity, thereby providing a previously unknown molecular target for regulating tumor progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16892036     DOI: 10.1038/nm1448

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  175 in total

1.  Altered methylation of the DNA repair gene MGMT is associated with neural tube defects.

Authors:  Susanna Tran; Li Wang; Jing Le; Jing Guan; Lihua Wu; Jizhen Zou; Zhen Wang; Jianhua Wang; Fang Wang; Xiaoli Chen; Lingling Cai; Xiaolin Lu; Huizhi Zhao; Jin Guo; Yihua Bao; Xiaoying Zheng; Ting Zhang
Journal:  J Mol Neurosci       Date:  2011-11-19       Impact factor: 3.444

Review 2.  From genes to drugs: targeted strategies for melanoma.

Authors:  Keith T Flaherty; F Stephen Hodi; David E Fisher
Journal:  Nat Rev Cancer       Date:  2012-04-05       Impact factor: 60.716

3.  Fluorescent imaging of cancer in zebrafish.

Authors:  Myron S Ignatius; David M Langenau
Journal:  Methods Cell Biol       Date:  2011       Impact factor: 1.441

Review 4.  Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.

Authors:  Peter C Gray; Wylie Vale
Journal:  FEBS Lett       Date:  2012-02-01       Impact factor: 4.124

Review 5.  Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence.

Authors:  Alyssa B Chinen; Chenxia M Guan; Jennifer R Ferrer; Stacey N Barnaby; Timothy J Merkel; Chad A Mirkin
Journal:  Chem Rev       Date:  2015-08-27       Impact factor: 60.622

Review 6.  Malignant Melanoma: Autoimmunity and Supracellular Messaging as New Therapeutic Approaches.

Authors:  Ion G Motofei
Journal:  Curr Treat Options Oncol       Date:  2019-05-06

7.  GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.

Authors:  Gidi Shani; Wolfgang H Fischer; Nicholas J Justice; Jonathan A Kelber; Wylie Vale; Peter C Gray
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

8.  Targeting nodal in conjunction with dacarbazine induces synergistic anticancer effects in metastatic melanoma.

Authors:  Katharine M Hardy; Luigi Strizzi; Naira V Margaryan; Kanika Gupta; George F Murphy; Richard A Scolyer; Mary J C Hendrix
Journal:  Mol Cancer Res       Date:  2015-03-12       Impact factor: 5.852

9.  Zebrafish as a model for cancer self-renewal.

Authors:  Myron S Ignatius; David M Langenau
Journal:  Zebrafish       Date:  2009-12       Impact factor: 1.985

10.  Plasticity underlies tumor progression: role of Nodal signaling.

Authors:  Thomas M Bodenstine; Grace S Chandler; Richard E B Seftor; Elisabeth A Seftor; Mary J C Hendrix
Journal:  Cancer Metastasis Rev       Date:  2016-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.